CalciMedica (NASDAQ:CALC) Receives “Buy” Rating from HC Wainwright
HC Wainwright restated their buy rating on shares of CalciMedica (NASDAQ:CALC – Free Report) in a report issued on Tuesday,Benzinga reports. They currently have a $16.00 target price on the stock. CalciMedica Stock Up 3.2 % Shares of CALC opened at $2.27 on Tuesday. The business’s 50 day moving average is $2.78 and its two-hundred […]
